関連する実験動画
Updated: Jun 29, 2025
11:12
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
13.8K
心弁疾患の評価と治療の未来
Partho P Sengupta1, Jolanda Kluin2, Seung-Pyo Lee3
1Division of Cardiovascular Diseases and Hypertension, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA; Cardiovascular Services, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA.
Lancet (London, England)
|March 30, 2024
まとめ
バルブ性心疾患 (VHD) の管理におけるイノベーションには,AI,デジタルツイン,バイオエンジニアリングが含まれています. これらの進歩により 診断やリスクの分別 パーソナライズされた治療が可能になり VHDの患者さんには 新しい希望が生まれています
科学分野:
- 心血管医学と生物医学工学
- 計算生物学と薬理学
背景:
- バルブ性心臓病 (VHD) の流行は高齢者集団で増加しており,診断と管理の課題を提起しています.
- 伝統的な治療法は特に高リスクの患者グループには 限界があります
- VHDの複雑さを解決するための革新的な戦略の必要性が高まっています.
研究 の 目的:
- バルブ性心臓病 (VHD) の診断と管理における最近の進歩をレビューする.
- VHDケアにおける 計算技術,薬理学,バイオエンジニアリングのイノベーションの影響を強調する.
- パーソナライズされたVHD治療における人工知能 (AI) とデジタル技術の可能性を探索する.
主な方法:
- VHDにおけるイメージング,トランスキャテーター技術,計算アプローチに関する現在の文献のレビュー.
- リスクの階層化と予測のためのデジタルツインを含むAIアプリケーションの探索.
- VHDの新薬学的戦略とマルチオミクスアプローチの検討
- 再生性心弁組織の開発におけるバイオエンジニアリングの取り組みに関する議論
主要な成果:
- AIとデジタルメソッドは VHDのスクリーニング,診断,治療計画を改善しています
- 画像と臨床データの統合により,VHDの重度の分類が改善されました.
- 人工知能によるデジタルツインは パーソナライズされた治療目標とリスク評価に役立ちます
- 新薬学的標的とマルチオミクスは VHDの進行を止めるための経路を特定しています.
- バイオエンジニアリングは 生きている心臓弁管の 開発を進めています
結論:
- コンピューター,薬学,バイオエンジニアリングのイノベーションが VHDの診断と管理を変化させています
- 早期発見,パーソナライズされた治療,高度な介入は VHD患者の治療結果を最適化するために不可欠です.
- これらの発見は 患者中心の研究と 改善されたVHDのケアに 重要な機会をもたらします
さらに関連する動画
関連する概念動画
01:16Heart Valves
4.6K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
4.6K
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
01:26Heart Failure Drugs: Inotropic Agents
578
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
578
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370